Ticanext 90 Tablet
Marketer
Shilpex Pharmysis
Salt Composition
Ticagrelor (90mg)
Overview Ticanext 90 Tablet
CardioGuard 90mg tablets are antiplatelet agents, working to inhibit the formation of dangerous blood clots within blood vessels. This action helps prevent strokes and heart attacks in individuals with pre-existing heart conditions. CardioGuard 90mg is also indicated for patients recovering from a recent heart attack, experiencing severe angina, or post-stent placement. It significantly reduces the risk of recurrent cardiac events, including further heart attacks, strokes, and clot formation within stents. Concomitant use with aspirin, another antiplatelet medication, is typically prescribed by your physician. CardioGuard 90mg can be taken with or without food, consistently at the same time daily. Continued use is crucial, even during periods of wellness, as discontinuation increases the risk of subsequent cardiovascular events. The most frequent adverse effect is increased bleeding tendency; minor injuries may bleed more profusely and for longer durations. While generally self-limiting, prolonged or excessive bleeding should be reported to your doctor. Some patients may experience mild dyspnea, typically resolving with ongoing therapy; however, worsening or persistent shortness of breath requires medical attention. CardioGuard 90mg is contraindicated in patients with active internal bleeding (e.g., stomach ulcers, intracranial hemorrhage) or hepatic impairment. Disclose any such conditions to your doctor prior to commencing treatment.
Uses of Ticanext 90 Tablet
Reducing the risk of cardiovascular events
Major Benefits of Ticanext 90 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the Ticanext 90 Tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable; however, consistent daily timing is recommended.
Common Side effects of Ticanext 90 Tablet:
- Bleeding
- Breathlessness
How to use Ticanext 90 Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticanext 90 Tablet can be consumed with or without food, though consistent timing is recommended.
How Ticanext 90 Tablet works:
Ticanext 90 mg tablets are a type of antiplatelet agent. Their mechanism of action involves inhibiting platelet aggregation, thus reducing the risk of dangerous thrombus development. This, in turn, minimizes the likelihood of a stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Ticanext 90 Tablet alongside alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Ticanext 90 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Ticanext 90 Tablet use while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticanext 90 Tablet.
KidneySAFE IF PRESCRIBED
Ticanext 90 Tablets are considered safe for individuals with kidney impairment; no dosage modification is advised. Data regarding Ticanext 90 Tablet use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use Ticanext 90 Tablet cautiously, potentially requiring dosage modification under medical supervision. Ticanext 90 Tablet is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Ticanext 90 Tablet :
Should you forget a Ticanext 90 Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ticanext 90 Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |


